Business
Jaguar Health Presenting March 12 at the Life Sciences Virtual Investor Forum to Provide Updates on Near-Term Catalysts
SAN FRANCISCO, CA / ACCESS Newswire / March 11, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and
About this update from Jaguar Health, Inc.
[{"type":"text","content":"SAN FRANCISCO, CA / ACCESS Newswire / March 11, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Thursday, March 12, 2026 at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com.Participation Instructions for Jaguar's Virtual Presentation at the Life Sciences Investor ForumWhen: Thursday, March 12, 2026 at 2:00 PM EasternRegistration link for conference: Click HereReplay: A replay of the webcast will be available following the conclusion of the conference.About the Jaguar Health Family of CompaniesJaguar Health, Inc. (\"Jaguar\") develops novel proprietary prescription drugs sustainably derived from plants for people with complicated gastrointestinal (\"GI\") disease states. Jaguar family companies Napo Pharmaceuticals, Inc. and Napo Therapeutics S.p.A. focus on the development and commercialization of novel crofelemer powder for oral solution for the treatment of rare and orphan gastrointestinal disorders with intestinal failure, including microvillus inclusion disease and short bowel syndrome.For more information about:Jaguar Health, visit https://jaguar.healthNapo Pharmaceuticals, visit napopharma.comNapo Therapeutics, visit napotherapeutics.comForward-Looking StatementsCertain statements in this press release constitute \"forward-looking statements.\" These include statements regarding Jaguar's expectation that Jaguar management will present at the March 2026 conference listed above. In some cases, you can identify forward-looking statements by terms such as \"may,\" \"will,\" \"should,\" \"expect,\" \"plan,\" \"aim,\" \"anticipate,\" \"could,\" \"intend,\" \"target,\" \"project,\" \"contemplate,\" \"believe,\" \"estimate,\" \"predict,\" \"potential\" or \"continue\" or the negative of these terms or other similar expressions. The forward-looking statements in this release are only predictions. Jaguar has based these forward-looking statements largely on its current expectations and projections about future events. These forward-looking statements speak only as of the date of this release and are subject to several risks, uncertainties, and assumptions, some of which cannot be predicted or quantified and some of which are beyond Jaguar's control. Except as required by applicable law, Jaguar does not plan to publi...